Franklin Milan Berger Insider Profile
4 Followers
Franklin Milan Berger, Director at Satellos Bioscience, holds 1.38M shares in Satellos Bioscience (Ticker: MSLE), holds 698.92K shares in BELLUS Health (Ticker: BLU), holds 784.40K shares in ESSA Pharma (Ticker: EPIX). Most recently, Franklin Milan Berger Bought ― shares of Satellos Bioscience on Jul 16, 2026 for an estimated value of $119.97K.
Franklin Milan Berger Satellos Bioscience (MSLE)Director
Satellos Bioscience (MSLE)
Director
Ranked #4,597 out of 109,193 Corporate Insiders
Profitable Transactions
5 out of 8 Profitable Transactions
Average Return
+49.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Franklin Milan Berger's holdings
Insider Roles
Director
Roles that Franklin Milan Berger holds in companies
Most Profitable Insider Trade
Stock:
BELLUS Health
(BLU)
(BLU)
Rating:Informative Buy
Date:Dec 18, 2017 - Dec 18, 2018
Return:+170.30%
The most profitable trade made by Franklin Milan Berger
Franklin Milan Berger's Trading History
Satellos Bioscience
Jul 16, 2026
Director
Informative Buy
119.97K
$11.70M
BELLUS Health
Oct 23, 2020
―
Informative Buy
400.00K
$10.30M
ESSA Pharma
―
―
―
$157.67K
List of latest transactions for each holding click on a transaction to see Franklin Milan Berger's performance on stock
You May Also Like
Franklin Milan Berger insider profile FAQ
What is the percentage of profitable transactions made by Franklin Milan Berger?
The percentage of profitable transactions made by Franklin Milan Berger is 63%.
What is the average return per transaction made by Franklin Milan Berger?
The average return per transaction made by Franklin Milan Berger is 49.80%.
What stocks does Franklin Milan Berger hold?
Franklin Milan Berger holds: MSLE, BLU, EPIX stocks.
What was Franklin Milan Berger’s latest transaction?
Franklin Milan Berger latest transaction was an Informative Buy of $119.97K.
What was Franklin Milan Berger's most profitable transaction?
Franklin Milan Berger’s most profitable transaction was an Informative Buy of BLU stock on December 18, 2017. The return on the trade was 170.30%.
What is Franklin Milan Berger's role in Satellos Bioscience?
Franklin Milan Berger's role in Satellos Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.